LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_001127510.3:c.6873A>T
APC
· NP_001120982.1:p.(Gln2291His)
· NM_001127510.3
GRCh37: chr5:112178164 A>T
·
GRCh38: chr5:112842467 A>T
Gene:
APC
Transcript:
NM_001127510.3
Final call
VUS
BP1 supporting
Variant details
Gene
APC
Transcript
NM_001127510.3
Protein
NP_001120982.1:p.(Gln2291His)
gnomAD AF
0.00023172731024073616 (v4.1)
ClinVar
Likely benign
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
BP1 supporting: p.(Gln2291His) is an APC missense change at codon 2291, outside the excluded codons 1021-1035.
Final determination:
No pathogenic or benign criteria-combination rule in the APC VCEP Version 2.1 framework matches the adjudicated criteria, so the variant remains a Variant of Uncertain Significance.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: c.6873A>T is a missense change producing p.(Gln2291His), not an APC null or canonical splice variant covered by PVS1. |
cspec
vcep_apc_specifications_supplementary_material_v2
vcep_fig_1_apc_pvs1_decision_tree_2023_10_20
|
| PS1 | Not met | Not met: p.(Gln2291His) has no documented same-amino-acid APC comparator among the VCEP's two established missense variants. |
cspec
|
| PS2 | Not assessed | Not assessed: no proband-level parental testing or confirmed maternity and paternity evidence is documented. |
cspec
|
| PS3 | Not assessed | Not assessed: no variant-specific validated damaging assay was available, and the APC protein-assay route is restricted to codons 959-2129 while this variant affects codon 2291. |
cspec
|
| PS4 | Not assessed | Not assessed: no usable phenotype-point total, case-control enrichment estimate, or exact-variant affected-individual evidence is available for PS4. |
cspec
vcep_table_1_262
PMID:22703879
PMID:22855150
PMID:23429431
PMID:23788249
PMID:24033266
PMID:24310308
PMID:25356965
PMID:25479140
|
| PM1 | N/A | Not applicable: the APC VCEP marks PM1 not applicable and supplies no authoritative domain-table entry for this gene. |
cspec
|
| PM2 | Not assessed | Not assessed: required gnomAD v2.1.1 non-cancer AF is unavailable; all-comers AFs are 0.000145204 and 0.000231727, above the VCEP PM2 threshold. |
cspec
gnomad_v2
gnomad_v4
|
| PM3 | N/A | Not applicable: the APC VCEP version 2.1 explicitly designates PM3 as not applicable for APC. |
cspec
|
| PM4 | N/A | Not applicable: APC VCEP designates PM4 unused, and c.6873A>T causes a missense substitution without a protein-length change. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| PM5 | Not assessed | Not assessed: zero p.Gln2291 comparator candidates were retrieved, but the comparator search recorded an HTTP 429 failure. |
cspec
pm5_candidates
|
| PM6 | Not assessed | Not assessed: no assumed-de-novo observation or de novo score is documented. |
cspec
|
| PP1 | Not assessed | Not assessed: no affected relatives, informative pedigree, or countable segregating meioses are documented. |
cspec
|
| PP2 | N/A | Not applicable: the APC VCEP excludes PP2 because missense variants are not a frequent disease mechanism in APC. |
cspec
|
| PP3 | Not met | Not met: SpliceAI max delta 0.00 and Pangolin scores 0.001/-0.006 do not support the APC VCEP's deleterious-splicing requirement. |
cspec
spliceai
|
| PP4 | N/A | Not applicable: the APC VCEP explicitly excludes PP4 because phenotype evidence is captured through its PS4 phenotype-point system. |
cspec
|
| PP5 | N/A | Not applicable: the APC VCEP excludes PP5, and ClinVar shows no exact-variant expert-panel classification for this variant. |
cspec
clinvar
|
| BA1 | Not assessed | Not assessed: the required gnomAD v2.1.1 non-cancer Popmax AF is unavailable; available all-comers grpmax FAFs are 0.00022755 and 0.00027477 versus 0.001. |
cspec
gnomad_v2
gnomad_v4
|
| BS1 | Not assessed | Not assessed: the required gnomAD v2.1.1 non-cancer Popmax AF is unavailable; available all-comers grpmax FAFs exceed the 0.00001 threshold but are not the specified source. |
cspec
gnomad_v2
gnomad_v4
|
| BS2 | Not assessed | Not assessed: available all-comers gnomAD v2.1 and v4.1 report zero homozygotes, but the VCEP-specified non-cancer homozygote dataset is unavailable. |
cspec
gnomad_v2
gnomad_v4
|
| BS3 | Not assessed | Not assessed: no variant-specific benign functional assay was available, and the APC protein-assay route is restricted to codons 959-2129 while this variant affects codon 2291. |
cspec
|
| BS4 | Not assessed | Not assessed: no affected, variant-negative relative with an APC phenotype score is documented. |
cspec
|
| BP1 | Met | Met, supporting: codon 2291 lies outside the VCEP's BP1 exception at codons 1021-1035. |
cspec
|
| BP2 | Not assessed | Not assessed: no documented phase, affected-proband observation, or second (Likely) Pathogenic APC variant is available for this case. |
cspec
|
| BP3 | N/A | Not applicable: APC VCEP designates BP3 unused, and p.(Gln2291His) is not an in-frame indel in a repetitive region. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| BP4 | N/A | Not applicable: the APC VCEP explicitly excludes BP4 for this missense variant, p.(Gln2291His). |
cspec
|
| BP5 | Not assessed | Not assessed: no documented alternate pathogenic polyposis-gene finding with the required colorectal polyposis phenotype establishes BP5. |
cspec
|
| BP6 | N/A | Not applicable: the APC VCEP excludes BP6, and no exact-variant ClinVar expert-panel benign or likely-benign classification is present. |
cspec
clinvar
|
| BP7 | N/A | Not applicable: BP7 is restricted to synonymous or qualifying intronic variants, whereas this variant is missense, p.(Gln2291His). |
cspec
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.